Endometrial 18F-FDG Uptake in Postmenopausal Patients Without Known Gynecologic Malignancy
| Characteristic | No. of patients | SUV ± SD | ||
|---|---|---|---|---|
| Mean | Range | |||
| No hormonal therapy | 105 | 1.7 ± 0.5 | 0.8–3 | |
| Hormonal therapy | 11 | 1.8 ± 0.6 | 0.9–2.6 | |
| Benign uterine pathology | 5 | 4.5 ± 2.1 | 2.3–8.2 | |
In 13 of the 134 postmenopausal patients, the uterus was not identified on CT. Endometrial SUV was measured in 121 postmenopausal patients without gynecologic malignancy. The SUV was calculated as the ratio of activity per cubic centimeter of tissue to activity in the injected dose per kilogram of patient body weight.